Abraham, Sylvie
Piarroux, Raphael
Zhou, Ying
Tesic, Vera
Abeleda, Ana
Houhou-Fidouh, Nadhira
Nicaise-Rolland, Pascale
Landraud, Luce
McLeod, Rima
Houzé, Sandrine http://orcid.org/0000-0001-9016-3847
Article History
Received: 12 July 2023
Accepted: 18 September 2023
First Online: 26 September 2023
Declarations
:
: The USA sending was exempted by University of Chicago investigational research board as it was impossible to link samples to patients and residual samples that are otherwise discarded were utilized. For French samples, only the staffs from the hospital had access to the laboratory results. Interpretation was performed anonymously. According to the French law, patients were informed that their samples might be used for research and they retained the right to oppose the use of their anonymized medical data for research purpose. Dedicated ethical approval and individual patient consent were not necessary for this type of research.
: Not applicable.
: In Paris and Lyon, the authors in Paris and Lyon have no relevant financial or non-financial interests to disclose except R Piarroux who was employed by the LDBio Company. In Chicago, at LDBio Diagnostics, Raphael Piarroux PharmD, PhD (RP) was the R&D Director Scientist until January 13, 2023, and during that time these studies were planned and discussed with RMc Leod (RMc). A patent application was submitted by D. Limonne, PharmD with the scientists at the University of Chicago and in Lyon, France in August 2018. This application is pending review in the United States Patent Office in accordance with the US Bayh Dole laws. This is for the development of the whole blood point of care test and the practical clinical utility of the ICT to guide treatment for gestational infection to prevent congenital toxoplasmosis. This is to insure its continued high-quality performance and reproducibility of the results described herein. In this collaborative work, the scientist RP and DL at LDBio provided insights and knowledge from their earlier work in creating the ICT. The scientists at LDBio did not interfere with the obtaining of samples, performing of the tests, the recording and interpretation of the results, nor the reported conclusions of any work at any academic site. All this work was performed independently in the academic centers. There was no payment to those at the University of Chicago.